Iyo, Masaomi
Chiba University
19 papers on CoChatORCID 0000-0002-5384-857X
Most cited papers
- Verified
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry
Treatment of Major DepressionTryptophan and brain disorders
Cited by 1,151
- Verified
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., et al. (1997) · Nature
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 710
- Verified
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews
Treatment of Major DepressionNerve injury and regeneration
Cited by 522
- Verified
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia
Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., & Iyo, M. (2006) · Biological Psychiatry
Tryptophan and brain disordersSchizophrenia research and treatment
Cited by 467
- Verified
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 270
- Verified
Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L. H., & Iyo, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Schizophrenia research and treatmentAmino Acid Enzymes and Metabolism
Cited by 267
- Verified
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease
Iyo, M., Namba, H., Fukushi, K., Shinotoh, H., Nagatsuka, S., Suhara, T., Sudo, Y., Suzuki, K., & Irie, T. (1997) · The Lancet
Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases
Cited by 259
- Verified
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
Shiina, A., Kanahara, N., Sasaki, T., Oda, Y., Hashimoto, T., Hasegawa, T., Yoshida, T., Iyo, M., & Hashimoto, K. (2015) · Clinical Psychopharmacology and Neuroscience
Schizophrenia research and treatmentTryptophan and brain disorders
Cited by 107
- Verified
Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
Suzuki, T., Kanahara, N., Yamanaka, H., Takase, M., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Psychiatry Research
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 81
- Verified
A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis
Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sasaki, T., et al. (2014) · Schizophrenia Research
Schizophrenia research and treatmentTreatment of Major Depression
Cited by 55
- Verified
Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
Takase, M., Kanahara, N., Oda, Y., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Journal of Psychopharmacology
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 54
- Verified
Transporting Cognitive Behavioral Therapy (CBT) and the Improving Access to Psychological Therapies (IAPT) project to Japan: preliminary observations and service evaluation in Chiba
Kobori, O., Nakazato, M., Yoshinaga, N., Shiraishi, T., Takaoka, K., Nakagawa, A., Iyo, M., & Shimizu, E. (2014) · The Journal of Mental Health Training, Education and Practice
Psychotherapy Techniques and ApplicationsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 47
- Verified
Deficits in auditory P50 inhibition in obsessive-compulsive disorder
Hashimoto, T., Shimizu, E., Koike, K., Orita, Y., Suzuki, T., Kanahara, N., Matsuzawa, D., Fukami, G., Miyatake, R., Shinoda, N., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Obsessive-Compulsive Spectrum DisordersPsychoanalysis and Psychopathology Research
Cited by 41
- Verified
Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up
Kimura, H., Kanahara, N., Sasaki, T., Komatsu, N., Ishige, M., Muneoka, K., Ino, H., Yoshimura, K., Yamanaka, H., Suzuki, T., et al. (2016) · Journal of Psychopharmacology
Schizophrenia research and treatmentTreatment of Major Depression
Cited by 26
- Verified
Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence
Okahisa, Y., Ujike, H., Kotaka, T., Morita, Y., Kodama, M., Inada, T., Yamada, M., Iwata, N., Iyo, M., Sora, I., et al. (2009) · Psychiatry and Clinical Neurosciences
Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology
Cited by 21
- Verified
A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study
Seki, Y., Nagata, S., Shibuya, T., Yoshinaga, N., Yokoo, M., Ibuki, H., Minamitani, N., Kusunoki, M., Inada, Y., Kawasoe, N., et al. (2016) · BMC Research Notes
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesDigital Mental Health Interventions
Cited by 19
- Verified
A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists
Tachibana, M., Kanahara, N., Oda, Y., Hasegawa, T., Kimura, A., & Iyo, M. (2024) · Journal of Clinical Sleep Medicine
Sleep and related disordersCircadian rhythm and melatonin
Cited by 17
- Verified
Long-Term Effectiveness of Cognitive Therapy for Refractory Social Anxiety Disorder: One-Year Follow-Up of a Randomized Controlled Trial
Yoshinaga, N., Kubota, K., Yoshimura, K., Takanashi, R., Ishida, Y., Iyo, M., Fukuda, T., & Shimizu, E. (2019) · Psychotherapy and Psychosomatics
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Assessments
Cited by 14
- Verified
A simple method for measuring glucose utilization of insulin-sensitive tissues by using the brain as a reference
Namba, H., Nakagawa, K., Iyo, M., Fukushi, K., & Irie, T. (1994) · European Journal of Nuclear Medicine
Medical Imaging Techniques and ApplicationsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free